NCT02190279View on ClinicalTrials.gov

18F-DCFBC PET/CT in Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

July 12, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

January 11, 2018

Conditions
Prostatic NeoplasmsProstate Cancer
Interventions
DRUG

18F DCFBC

Each subject will receive a single intravenous (i.v.) dose of 18F DCFBC by bolus injection at a rate of approximately 1 ml/3-5 sec.

DRUG

Sodium (Na)18F positron emission tomography (PET)/computed tomography (CT)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02190279 - 18F-DCFBC PET/CT in Prostate Cancer | Biotech Hunter | Biotech Hunter